| ORIGINAL ARTICLE |
|
| Year : 2015 | Volume
: 6
| Issue : 2 | Page : 383-387 |
|
|
Phenotypic detection of extended spectrum β-lactamase and Amp-C β-lactamase producing clinical isolates in a Tertiary Care Hospital: A preliminary study
S Sageerabanoo1, A Malini2, T Mangaiyarkarasi3, G Hemalatha4
1 Department of Microbiology, Dhanalakshmi Srinivasan Medical College, Perambalur, Tamil Nadu, India
2 Department of Microbiology, Indira Gandhi Medical College and Research Institute (Government of Puducherry Institute), Puducherry, India
3 Department of Microbiology, Sri Manakula Vinayagar Medical College, Puducherry, India
4 Department of Microbiology, Aarupadai Veedu Medical College, Puducherry, India
Correspondence Address:
Dr. A Malini
Department of Microbiology, Indira Gandhi Medical College and Research Institute (Government of Puducherry Institute), Puducherry
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0976-9668.160014
|
|
|
Background: Production of β-lactamase enzymes by Gram-negative bacteria is the most common mechanism to acquire drug resistance to β-lactam antibiotics. Limitations in detecting extended spectrum β-lactamases (ESBL) and Amp-C β-lactamases have contributed to the uncontrolled spread of bacterial resistance and are of significant clinical concern. Materials and Methods: A total of 148 samples was selected on the basis of resistance against third-generation cephalosporin for screening ESBLs and Amp-C β-lactamases production. These multidrug-resistant strains were phenotypically screened for ESBL production by phenotypic confirmatory disc diffusion test and double disc synergy test. Modified three-dimensional method was used for Amp-C β-lactamases detection. Result: Among the 148 isolates, 82 (55.40%) were ESBL producers, and 115 (77.70%) were Amp-C β-lactamases producers. Co-existence of ESBL and Amp-C was observed in 70 (47.29%) isolates. Escherichia coli was the most common ESBL and Amp-C β-lactamase producer. All ESBL producers were highly resistant to ciprofloxacin (83.10%), cotrimoxazole (95.27%), and gentamicin (89.18%). However, these bacterial strains were sensitive to imipenem 146 (98.64%) and piperacillin/tazobactam 143 (96.62%). Conclusion: Our study showed that ESBL producing organisms were not only resistant to cephalosporins but also to other group of drugs and also that multiple mechanisms play a role in drug resistance among Gram-negative bacteria. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
